Efficacy and Tolerability of Long-Acting Injectable Formulation of Nalmefene (Nalmefene Consta 393.1 mg) for Opioid Relapse Prevention: A Multicentre, Open-Label, Randomised Controlled Trial

World Journal of Neuroscience

World Journal of Neuroscience

World Journal of Neuroscience

ISSN Print: 2162-2000
ISSN Online: 2162-2019
www.scirp.net/journal/wjns
E-mail: [email protected]

Citations

Journals Menu

Guidelines & Policies

"Efficacy and Tolerability of Long-Acting Injectable Formulation of Nalmefene (Nalmefene Consta 393.1 mg) for Opioid Relapse Prevention: A Multicentre, Open-Label, Randomised Controlled Trial"
written by Sead Kadric, Hanns Mohler, Olli Kallioniemi, Karl Heinz Altmann,
published by World Journal of Neuroscience, Vol.9 No.3, 2019

has been cited by the following article(s):

Google Scholar
CrossRef

No relevant information.

Contact us

	[email protected]
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.

Top